ArticleOncotarget2016

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer.

Changping Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.